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Associations of depressive symptoms with gender,
body mass index and dyspnea in primary care
COPD patients
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Chavannes NH, Huibers MJH, Schermer TRJ, Hendriks A, van Weel C, Wouters EFM and
van Schayck CP. Associations of depressive symptoms with gender, body mass index and
dyspnea in primary care COPD patients. Family Practice 2005; 22: 604–607.
Background. It has been suggested that severe COPD is associated with depressive
symptoms, possibly linked to exacerbations, dyspnea and hospitalisation. However, scarce data
are available in primary care where most patients suffer from mild or moderate disease.
Objective. We aimed to reveal associations of depressive symptoms with demographic and
clinical characteristics in mild to moderate COPD.
Methods. Cross-sectional data on lung function measurements, exacerbation frequency,
dyspnea, comorbidity, smoking behaviour, body mass index (BMI), age, gender and depressive
symptoms (Beck Depression Inventory) of 147 primary care patients were assessed in multiple
logistic regression analyses.
Results. Patients suffered from mild to moderate obstruction (FEV1 63.6% pred, range 45.1%
to 82.1%). Female gender (OR 4.8, 95% CI 2.1 to 10.8), BMI  25 (OR 0.4, 95% CI 0.2 to 0.8) and
current smoking (OR 2.3, 95% CI 1.01 to 5.3) were univariately associated with depressive
symptoms, while in a multivariate logistic model only female gender (OR 4.0, 95% CI 1.6 to 9.9),
BMI  25 (OR 0.3, 95% CI 0.1 to 0.7) and dyspnea (OR 1.8, 95% CI 1.1 to 2.9) were independently
associated with depressive symptoms.
Conclusion. These data suggest that in primary care depressive symptoms in COPD seem to
be related with female gender, BMI and dyspnea. In this study, lung function, exacerbation rate,
smoking behaviour, age and comorbidity are not independently associated with depressive
symptoms in COPD of mild to moderate severity.
Introduction
Several studies have assessed the occurrence of
depressive symptoms in COPD patients, reporting
prevalences of up to 42% in moderate to severe COPD.1–3
Depression was found to be the strongest independent
predictor of mortality of COPD patients admitted to
hospital for an acute exacerbation.4 Depression and
anxiety predict health related quality of life in COPD
better than traditional lung function parameters,1 while
the domain mental health of HRQL is scored worse than
in patients with hypertension, diabetes, heart failure,
arthritis and chronic low back pain. However, few studies
assessing prevalence of depression have been of sufficient
methodological quality,5 and even less have investigated
the primary care patient population, where most COPD
is of mild to moderate severity. Underdiagnosis is a
common finding, which is caused by both doctor- and
patient-related factors.6 Recent studies found a
relationship between depression and emergency visits
and postulated that exacerbations may play an important
role in the prevalence of depression,7 while severely
impaired lung function was reported to be another key
factor8 as well as living alone, reversibility of FEV1%
predicted, respiratory symptoms and physical
impairment.9 However, despite reported findings the role
of depression in COPD is still poorly understood.
Recently, mortality from COPD is reported to rise
strongly, mainly because of increasing numbers of female
patients, now surpassing death rates of male COPD in the
United States.10 But also in Europe this epidemiological
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shift starts to occur.11,12 Research in COPD has focused
on males, since these were the most common subjects
available, but contains very little data on female patients.
Moreover, in primary care most patients suffer from mild
to intermediate disease, do not attend pulmonary clinics
and as a result have not been studied thoroughly. The aim
of this study was to reveal associations of depression with
demographic and clinical characteristics of COPD
patients who are seen in primary care.
Methods
We conducted a cross-sectional study to investigate
possible relations between depressive symptoms and
lung function indices, exacerbation rate, smoking behav-
iour, dyspnea, age, body mass index (BMI), gender and
comorbidity. Subjects were primary care patients with
physician-diagnosed mild to moderate COPD, who
participated in the COOPT Study, a three year ran-
domized clinical trial conducted between 1998 and 2003
in 46 Dutch general practices.13 In this study, reversibility
was not an exclusion criterion, but a history of asthma,
allergic rhinitis or atopy was. 147 patients who were
measured at the Academic Hospital Maastricht were
current or past smokers between 30 and 75 years of age
and fulfilled the European Respiratory Society criteria
for a clinical diagnosis of COPD.14 Patients with an
FEV1 below 40% of predicted were excluded.
Depressive symptoms were measured with the Beck
Depression Inventory (BDI).15 A score  10 on the BDI
indicates an elevated risk for mood disturbances. Several
independent variables were investigated for their
association with depressive symptoms. Exacerbation rate
was defined as number of registered physician contacts
per year for increased respiratory symptoms, necessitat-
ing a medical intervention. Dyspnea was measured by the
Medical Research Council (MRC) Dyspnea Index.16
BMI was considered aberrant below 21 or above 25.
Comorbidity was defined as the number of co-morbid
chronic conditions as registered by the primary care
physician. All participants were current or former
smokers with at least five pack-years smoking history.
Lung function measurements included flow-volume
before and after bronchodilatation, using Micromedical
Microloop II spirometers and Spirare software.
Associations between variables were first investigated
univariately, after which all significant variables were
tested in an adjusted backward regression model. All
analyses were performed using SPSS 10.0 software.
Results
Table 1 summarizes the characteristics of the subgroups
with and without depressive symptoms and the total
study population. Patients expressed mild to moderate
obstruction (FEV1 63.6% pred., range 45.1% to 82.1%),
TABLE 1 Associations between demographic and clinical characteristics and the risk for depression (BDI  10)
Total Depressive No depressive OR 95% CI OR 95% CI P-value
(n  147) symptoms symptoms adjusted
(n  40) (n  107)
BDI 7.1 (7.0) 16.1 (6.8) 3.7 (2.8) – – – – –
Gender (f/m) 36/111 19/21 17/90 4.8 2.1 to 10.8 4.0 1.6 to 9.9 0.003
Age (yrs) 58.6 (10.2) 57.2 (9.5) 59.2 (10.4) 1.0 0.95 to 1.02 – – –
BMI 26.2 (4.1) 25.1 (4.3) 26.6 (3.9) 0.9 0.8 to 1.00 – – –
BMI  21 (n) 14 5 9 1.6 0.5 to 5.0 – – –
BMI  25 (n) 88 17 71 0.4 0.2 to 0.8 0.3 0.1 to 0.7 0.007
FEV1 (%pred.) 63.6 (18.5) 63.9 (15.2) 63.4 (19.7) 1.0 0.98 to 1.02 – – –
FEV1/FVC 61.5 (14.3) 62.0 (16.0) 61.4 (13.6) 1.0 0.98 to 1.02 – – –
Reversibility (%) 6.7 (6.2) 7.1 (5.3) 6.6 (6.5) 1.0 0.96 to 1.08 – – –
Pack–years (yrs) 26.5 (4.1) 29.4 (16.6) 25.4 (14.9) 1.0 0.99 to 1.04 – – –
Smoking 95/52 31/9 64/43 2.3 1.01 to 5.3 2.2 0.8 to 5.9 0.106
(current/former)
Exacerbation 0.8 (0.7) 0.9 (0.7) 0.8 (0.8) 1.2 0.73 to 1.9 – – –
frequency (n/yr)
Comorbidity (n/pt) 0.6 (1.1) 0.7 (1.3) 0.6 (1.0) 1.1 0.78 to 1.5 – – –
MRC Dyspnea 2.0 (0.9) 2.3 (0.7) 1.9 (0.9) 1.5 0.99 to 2.3 1.8 1.1 to 2.9 0.016
Index
Figures are means (SD) unless stated otherwise.
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with an average of 26.5 pack-years smoked. Female
gender (OR 4.8, 95% CI 2.1 to 10.8), BMI  25 (OR 0.4,
95% CI 0.2 to 0.8) and current smoking (OR 2.3, 95%
CI 1.01 to 5.3) were univariately associated with
depressive symptoms (Table 2). In a multivariate logistic
model only female gender (OR 4.0, 95% CI 1.6 to 9.6),
BMI  25 (OR 0.3, 95% CI 0.1 to 0.7) and dyspnea (OR
1.8, 95% CI 1.1 to 2.9) were independently associated
with depressive symptoms.
Discussion
This study was aimed at exposing possible associations
between clinical characteristics of COPD and
depressive symptoms. In mild to moderate COPD we
cannot confirm an association with exacerbations or
comorbidity, probably because of a low exacerbation
frequency and less impaired lung function. We did,
however, find a quite strong association with female
gender, and to a lesser extent with elevated BMI and
dyspnea. Current smoking behaviour did not remain
associated with depressive symptoms in the multivariate
model. Interestingly, we found fewer depressive symp-
toms in patients with an elevated BMI, while the inverse
relation with BMI  21 did not reach significance,
probably due to low patient numbers. The importance of
BMI and dyspnea has been recognized in recent
guidelines,17 but not the role of female gender. From
previous epidemiological studies we learn that females
are almost twice as likely to suffer from major
depressive episodes as men.18 However, considering the
magnitude of the association we found, could it be that
females in our study expressed a different pattern of
emotional coping than our male COPD patients? A
small Finnish community based study19 reported earlier
that female COPD patients experienced more feelings
of dissatisfaction with life than controls, and had more
mental health problems than male patients. In an Italian
study female gender was associated with a greater
impact of COPD on health status.20 Norwegian females
reported more symptoms and lower self-rated health
compared with males with similar smoking burden.21
However, we realize that measuring depressive
symptoms can be influenced by gender in itself. From a
comparative study on depression measurement instru-
ments, it follows that mean BDI scores were indeed
borderline higher in females than in males, as a result of
possibly gender-biased items.22 Major depression in the
elderly presents with partially different symptoms in
men and women. This suggests that gender influences
perception and expression of depressive syndromes.23
Higher levels of catastrophic withdrawal coping strategy
and lower levels of self-efficacy of symptom manage-
ment are associated with higher levels of depression,
anxiety and quality of life.24 It is therefore important to
investigate this possible association between gender and
depressive symptoms further, since female patients with
COPD are a rapidly increasing patient category, and this
will likely require more attention from the primary care
provider. At present, there seems to be a great disparity
between prevalence of anxiety and depression symptoms
in COPD patients and the recognition and treatment of
these symptoms by primary care providers.25 Indeed,
there is an inverse relationship between the patients’
perceived access to health care and depressive symptoms
in chronic pulmonary disease.26
Can we achieve better results? Especially in primary
care, the answer must be sought in integrated care models
when taking care of these complex patients.27 Compared
with control groups, decline in depressive symptoms
and increased exercise capacity occurred in patients
with COPD after a brief rehabilitation of 3 weeks.28
Moreover, treating depression in primary care setting can
prevent unnecessary hospitalizations and reduce health
care costs.29
Conclusions
These data suggest that in primary care, depressive
symptoms in COPD seem to be related to female gender
and the presence of dyspneic complaints, while patients
with an elevated BMI report less depressive symptoms.
Based on our findings and previous reports in the
literature we hypothesize that females with COPD may
express a different disease coping pattern, including
more depressive symptoms, which deserves further
research. In this study, lung function, exacerbation rate,
smoking behaviour, age and comorbidity are not
independently associated with depressive symptoms in
COPD of mild to moderate severity.
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